EUVIMED · CrossrefZeitschrift
Recent Patents on Anti-Cancer Drug Discovery
ISSN 1574-8928 · Bentham Science Publishers Ltd.
Neueste Artikel
A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of NHWD-870 HCl in Patients with Lymphoma and Other Advanced Solid Tumors
The ER Stress-related Gene Prognostic Signature for Predicting Chemosensitivity and Prognosis in AML
A Single-arm, Open-label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-small Cell Lung Cancer
Exploring the Molecular Mechanisms and Biological Effects of CELF2 in the Development of Gastric Cancer
Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression
Curcumin Inhibits the Growth of Hepatocellular Carcinoma via the MARCH1-mediated Modulation of JAK2/STAT3 Signaling
Tyrosine Kinase Inhibitor Lenvatinib Causes Cardiotoxicity by Inducing Endoplasmic Reticulum Stress and Apoptosis through Activating ATF6, IRE1α and PERK Signaling Pathways
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies
Co-delivery of Siape1 and Melatonin by 125 I-loaded PSMA-targeted Nanoparticles for the Treatment of Prostate Cancer
1,3,4-Oxadiazoles as Anticancer Agents: A Review
Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy
Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials
Research and Patents Status of Selected Phytochemicals Against Cancer: How Close and How Far?
Application of Nano Drug Delivery System (NDDS) in Cancer Therapy: A Perspective
ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways
Non-histone Methylation of SET7/9 and its Biological Functions
Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells
Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival
BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients
Terpenes with Antitumor Activity: A Patent Review
Developments in the Application of 1,2,3-Triazoles in Cancer Treatment
Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease
Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents
CS5931, A Novel Marine Polypeptide, Inhibits Migration and Invasion of Cancer Cells Via Interacting with Enolase 1
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the A rt and New Perspectives with Patents Recently Applied
Anti-Cancer Effect of α-Solanine by Down-Regulating S100P Expression in Colorectal Cancer Cells
Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review
Cabozantinib in Thyroid Cancer
New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line
Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
EUVIMED